Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
3.665
+0.095 (2.66%)
At close: May 30, 2025, 4:00 PM
3.660
-0.005 (-0.14%)
After-hours: May 30, 2025, 4:04 PM EDT

Contineum Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-49.83-42.2622.72-24.25-29
Depreciation & Amortization
0.280.260.20.330.33
Other Amortization
----0.15
Loss (Gain) From Sale of Assets
0.05-0.02-0-
Loss (Gain) From Sale of Investments
-3.21-3.95-2.660.250.39
Stock-Based Compensation
8.616.82.221.931.75
Other Operating Activities
0.850.98-2.112.90.01
Change in Accounts Payable
3.051.14--0.23-0.11
Change in Other Net Operating Assets
0.934.19-1.02-1.040.22
Operating Cash Flow
-39.28-32.8519.35-20.12-26.27
Capital Expenditures
-0.41-0.51-0.41-0.12-0.17
Sale of Property, Plant & Equipment
0.020.02---
Investment in Securities
-63.16-69.25-65.1522.42-64.8
Investing Cash Flow
-63.56-69.74-65.5722.3-64.97
Long-Term Debt Repaid
---3.75-1.25-
Net Debt Issued (Repaid)
---3.75-1.25-
Issuance of Common Stock
108.91090.160.020.11
Repurchase of Common Stock
---0.03-0-
Other Financing Activities
0.14--0.34--
Financing Cash Flow
109.0410956.18-1.2479.84
Net Cash Flow
6.216.429.960.94-11.4
Free Cash Flow
-39.7-33.3618.94-20.24-26.43
Free Cash Flow Margin
--37.87%--
Free Cash Flow Per Share
-1.57-1.725.58-9.02-12.53
Cash Interest Paid
--0.150.230.22
Cash Income Tax Paid
--0.45--
Levered Free Cash Flow
-26.34-20.8713.08-12.61-
Unlevered Free Cash Flow
-26.34-20.8713.21-12.37-
Change in Net Working Capital
-2.11-4.39-1.170.31-
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q